Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder

Psychopharmacology

Volumn 213, Issue 2-3, 2011, Pages 593-602

  Bell, Caroline ^a   Hood, Sean ^c   Potokar, John ^b   Nash, Jon ^b   Adrover, Mariona ^d   Frampton, Chris ^a   Hince, Dana ^c   Rich, Ann ^b   Argyropoulos, Spilios ^b   Nutt, David ^b,e  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d Hospital Psiquiatrico (GESMA)   (Spain)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT; Cognitive behavioural therapy; Panic disorder; Tryptophan depletion

Indexed keywords

FLUMAZENIL; TRYPTOPHAN;

ADULT; AMINO ACID BLOOD LEVEL; ANXIETY; ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; NEUROLOGICAL AND SENSORIAL PROCEDURES; PANIC; PRIORITY JOURNAL; PROVOCATION TEST; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; RAPID TRYPTOPHAN DEPLETION; SPIELBERGER STATE ANXIETY INVENTORY; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; ANXIETY; COGNITIVE THERAPY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FLUMAZENIL; GABA MODULATORS; HUMANS; MALE; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; TRYPTOPHAN; YOUNG ADULT;

EID: 79952488261     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1696-z     Document Type: Article

References (39)

1. American Psychiatric Association for theWork Group on Panic Disorder (2009) Practice guideline for the treatment of patients with panic disorder (second edition). http://www.psychiatryonline.com/pracGuide/pracGuideTopic-9. aspx
2. Argyropoulos S, Hood SD, Adrover M, Bell CJ, Rich A, Nash JR, Rich NC, Witchel HJ, Nutt DJ (2004) Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biol Psychiatry 56:503-509 (Pubitemid 39278248)
3. Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH (1994) Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry 51:309-317 (Pubitemid 24127304)
4. Battaglia M, Perna G (1995) The 35% CO2 challenge in panic disorder: optimization by receiver operating characteristic (ROC) analysis. J Psychiatr Res 29:111-119
5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
6. Bell C, Forshall S, AdroverM, Nash J, Hood S, Argyropoulos S, Rich A, Nutt DJ (2002) Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. J Psychopharmacol (Oxf) 16:5-14 (Pubitemid 34273068)
7. Bell CJ, Hood SD, Nutt DJ (2005) Acute tryptophan depletion. Part II: clinical effects and implications. Aust N Z J Psychiatry 39:565-574 (Pubitemid 41613445)
8. Berney A, Sookman D, Leyton M, Young SN, Benkelfat C (2006) Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients. Biol Psychiatry 59:853-857
9. Booij L, Van der Does W, Benkelfat C, Bremner JD, Cowen PJ, Fava M, Gillin C, Leyton M, Moore P, Smith KA, Van der Kloot WA (2002) Predictors of mood response to acute tryptophan depletion. A reanalysis. Neuropsychopharmacology 27:852-861 (Pubitemid 35335901)
10. Chambless DL, Caputo GC, Bright P, Gallagher R (1984) Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 52:1090-1097 (Pubitemid 15082536)
11. Clark DM (1986) A cognitive approach to panic. Behav Res Ther 24:461-470
12. Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder M (1994) A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 164:759-769 (Pubitemid 24186895)
13. Corchs F, Nutt DJ, Hood S, Bernik M (2009) Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorder. Biol Psychiatry 66:17-24
14. Coupland NJ, Lillywhite A, Bell CE, Potokar JP, Nutt DJ (1997) A pilot controlled study of the effects of flumazenil in posttraumatic stress disorder. Biol Psychiatry 41:988-990 (Pubitemid 27213711)
15. Coupland NJ, Bell C, Potokar JP, Dorkins E, Nutt DJ (2000) Flumazenil challenge in social phobia. Depress Anxiety 11:27-30 (Pubitemid 30131878)
16. Deakin JF, Graeff FG (1991) 5HT and mechanisms of defence. J Psychopharmacol (Oxf) 5:305-315
17. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry 47:411-418
18. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H (2004) Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61:34-41 (Pubitemid 38044639)
19. Gorman JM, Browne ST, Papp LA, Martinez J, Welkowitz L, Coplan JD, Goetz RR, Kent J, Klein DF (1997) Effect of antipanic treatment on response to carbon dioxide. Biol Psychiatry 42:982-991 (Pubitemid 27496428)
20. Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000) Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157:493-505 (Pubitemid 30191187)
21. Guy W (1976) ECDEU Assessment manual for psychopharmacology. US Department of Health, Education, andWelfare,Washington, DC
22. Haynes PL, McQuaid JR, Kelsoe J, Rapaport M, Gillin JC (2004) Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals. J Affect Disord 83:253-262 (Pubitemid 39536204)
23. Klein DF (1993) False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 50:306-317
24. Mavissakalian MR, Perel JM, Talbott-Green M, Sloan C (1998) Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia. Biol Psychiatry 43:848-854 (Pubitemid 28288385)
25. McNally RJ, Riemann BC, Kim E (1990) Selective processing of threat cues in panic disorder. Behav Res Ther 28:407-412 (Pubitemid 20333693)
26. Miller HE, Deakin JF, Anderson IM (2000) Effect of acute tryptophan depletion on CO2-induced anxiety in patients with panic disorder and normal volunteers. Br J Psychiatry 176:182-188 (Pubitemid 32734846)
27. Neumeister A, Hu XZ, Luckenbaugh DA, Schwarz M, Nugent AC, Bonne O, Herscovitch P, Goldman D, Drevets WC, Charney DS (2006) Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 63:978-986 (Pubitemid 44330456)
28. Nutt DJ, Glue P, Lawson C, Wilson S (1990) Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 47:917-925 (Pubitemid 20348479)
29. O'Reardon JP, Chopra MP, Bergan A, Gallop R, DR J, Crits- Christoph P (2004) Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants. Biol Psychiatry 55:957-959 (Pubitemid 38526310)
30. 2 hyperreactivity and short-term treatment outcome. J Clin Psychopharmacol 22:300-308
31. Prasko J, Horacek J, Zalesky R, Kopecek M, Novak T, Paskova B, Skrdlantova L, Belohlavek O, Hoschl C (2004) The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuroendocrinol Lett 25:340-348 (Pubitemid 39625042)
32. Rassovsky Y, Kushner MG, Schwarze NJ, Wangensteen OD (2000) Psychological and physiological predictors of response to carbon dioxide challenge in individuals with panic disorder. J Abnorm Psychology 109:616-623 (Pubitemid 32096221)
33. Sakai Y, Kumano H, Nishikawa M, Sakano Y, Kaiya H, Imabayashi E, Ohnishi T, Matsuda H, Yasuda A, Sato A, Diksic M, Kuboki T (2006) Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. Neuroimage 33:218-226 (Pubitemid 44397589)
34. 2 challenge in patients with panic disorder. J Abnorm Psychology 106:630-638
35. Schruers K, Klaassen T, Pols H, Overbeek T, Deutz NEP, Griez E (2000) Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients. Psychiatry Res 93:179-187 (Pubitemid 30175948)
36. ShearMK, Fyer AJ, BallG, Josephson S, FitzpatrickM, Gitlin B, Frances A, Gorman J, Liebowitz M, Klein DF (1991) Vulnerability to sodium lactate in panic disorder patients given cognitive-behavioral therapy. Am J Psychiatry 148:795-797
37. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59:22-33
38. Smith KA, Fairburn CG, Cowen PJ (1997) Relapse of depression after rapid depletion of tryptophan. Lancet 349:915-919 (Pubitemid 27139821)
39. Spielberger C, Gorsuch R, Lushene R (1970) Manual for the state trait anxiety inventory. Consulting Psychologists Press, Palo Alto